Western Regional Blog – BC, YK, AB, NWT and Nunavut
February 28, 2018 – Advocates pressing for federal investment to address ovarian cancer are today re-iterating the need for specific and targeted investments in ovarian cancer research. While Budget 2018 made important investments in the Canadian Institutes of Health Research (CIHR), the lack of funding earmarked for Canada’s most fatal women’s cancer means that thousands of women who will be diagnosed with ovarian cancer this year must continue pressing for more research.
Ovarian Cancer Canada has called for an immediate and additional $10M in federal funding for ovarian cancer research, which will enable Canadian scientists to develop new research models, identify and prioritize new treatments, and maximize patient enrollment in clinical trials.
To read the full press release, click here.